India, Oct. 12 -- PharmEasy parent API Holdings narrowed its consolidated net loss by 67% to Rs.520 Cr in the fiscal year ended March 2026 (FY26) from Rs.1,572 Cr in the previous fiscal, with its operating revenue growing 12.7% YoY to Rs.6,618.5 Cr.

The company attributed the improvement to its focus on customer experience, higher-value profitable segments, capacity utilisation, increasing wallet share and leveraging digital capabilities.

In its FY26 annual report, API Holdings said it improved margins by focusing on higher-margin products, particularly its private label brands, and optimising discounts in its B2R business.

Including other income of Rs.70.8 Cr, the company's total revenue stood at Rs.6,689.2 Cr for FY26. However, it co...